Apply for product authorisation by the deadlines to keep your products on the NI market The following EU Biocidal Products Regulation (EU BPR) active substance approval dates are coming up: Formic acid (CAS 64-18-6 EC 200-579-1) in product types 2, 3, 4 and 5
1 November 2024
Chrysanthemum cinerariaefolium, extract from open and mature flowers of Tanacetum cinerariifolium obtained with hydrocarbon solvents (CAS 89997-63-7 EC 289-699-3) in product type 18
1 February 2025
Chrysanthemum cinerariaefolium, extract from open and mature flowers of Tanacetum cinerariifolium obtained with supercritical CO2 (CAS 89997-63-7 EC 289-699-3) in product type 18
1 February 2025
Reaction mass of N,N-didecyl-N-(2-hydroxyethyl)-N-methylammonium propionate and N,N-didecyl-N-(2-(2-hydroxyethoxy)ethyl)-N-methylammonium propionate and N,N-didecyl-N-(2-(2-(2-hydroxyethoxy)ethoxy)ethyl)-N-methylammonium propionate (CAS N/A EC N/A) in product types 2 and 4
1 February 2025 If you supply biocidal products containing these active substances in the relevant product types, donât forget to apply for EU BPR product authorisation by the dates above to keep them on the NI market. Submit a notification by the deadline to keep active substances in the EU Review Programme The European Chemicals Agency (ECHA) has published open invitations to provide an opportunity for a person, company or task force/consortium to notify an intention to take up or take over the role of participant in the EU Review Programme for the following active substance/product type combinations. Â This affects NI. Anyone wishing to support one of the active substance/product type combinations listed below in the EU will need to submit a notification to ECHA by the following deadlines: Reaction products of 5,5-dimethylhydantoin, 5-ethyl-5-methylhydantoin with chlorine (DCEMH) (CAS 89415-87-2 EC 401-570-7) in product type 11
14 November 2024
Reaction products of 5,5-dimethylhydantoin, 5-ethyl-5-methylhydantoin with bromine and chlorine (DCDMH) (CAS N/A EC N/A) in product type 11
14 November 2024 If a notification to take over the role of participant is not received, these active substance/product type combinations will be subject to an EU non-approval decision. Â This means the active substances will no longer be able to be used in biocidal products of the relevant product type in NI. In addition articles treated with such products will no longer be able to be placed on the market in NI. HSE will provide separate updates on these where relevant. Â If you are aware of any disproportionate negative impacts that are likely to arise from the non-approval of any of the active substance/product type combinations listed above, please contact us. | 